James Swartz has spent a dozen years refining an underappreciated biotech technique into a radical new vaccine approach that could quickly protect billions of people from the next COVID-19-level pandemic.
James Swartz has spent a dozen years refining an underappreciated biotech technique into a radical new vaccine approach that could quickly protect billions of people from the next COVID-19-level pandemic.